← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

Chief Scientific Officer Sharon Shacham sold $220K of Karyopharm Therapeutics Inc.

Sold$220,246
$12.12Price
18,167Shares
−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Thu, Feb 17. Filed Tue, Feb 22, 11:15 AM ET, during the session. Not investment advice.